PetVivo, Inc. is a wholly owned subsidiary of PetVivo Holdings, Inc. (OTC: PETV) based in Minneapolis, Minnesota. PetVivo is an emerging biomedical device company focused on the licensing and commercialization of medical devices and other therapeutics for pets. SNNLive caught up with John Lai, CEO of PetVivo Holdings, Inc. at the Growth Capital Expo 2015 in Las Vegas, NV.
Mr. Lai starts with an overview of the company. “The company focuses on pet therapeutics, we have taken human therapeutics and applied them to companion animals,” as Mr. Lai states.
He goes on to describe the company’s recent acquisition of the Gel-Del Technologies (See news release here: PetVivo Holdings & Gel-Del Technologies Merger Completed), “We just completed our acquisition of Gel-Del Technologies. It’s been in the making for about a year and a half, and it’s a relief to have it done and have those high-value patents within the parent company.” He continues to describe what these acquired high-value patents mean for PetVivo.
Mr. Lai then explains Kush™, their lead product the company developed for the treatment of osteoarthritis and lameness. For more information about PetVivo Holdings, Inc., go to: www.PetVivo.com
© 2017 Stock News Now
Supported by Superior Web Solutions